Ragasa, Ysrael Edrich M.
HRN: 27-27-35 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/28/2025
CEFOTAXIME 500MG (VIAL)
06/28/2025
07/05/2025
IV
170mg
Q6
Sepsis Neonatorum
Checking Initial Appropriateness